NCT01227369已完成不适用
Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4,376
- 试验地点
- 1
- 主要终点
- Mean of composite satisfaction score (CSS) of OPSAT-QTM
研究概览
简要总结
Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
详细描述
Cross-sectional quality of life survey using self-administered OPSAT-QTM questionnaire in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Who have been diagnosed with postmenopausal osteoporosis by physician Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire Who provide informed consent for study participation
排除标准
- •Do not understand the contents of the questionnaire
结局指标
主要结局
Mean of composite satisfaction score (CSS) of OPSAT-QTM
时间窗: 0day
次要结局
- Mean of subscale satisfaction scores of OPSAT-QTM(oday)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study on Factors Osteoporosis Quality-of-life in Japanese SubjectsJPRN-UMIN000003481Japan Association of Health Service6,000
已完成
不适用
Health-related quality of life of postmenopausal women treated with Letrozole as adjuvant therapy for hormone receptor-positive early breast cancer (SBCCSG-15)postmenopausal breast cancerJPRN-UMIN000001552PO Saitama Breast Cancer Clinical Study Group (SBCCSG)200
已完成
4 期
A clinical trial to assess the effect on quality of life in post menoapausal osteoporotic women with salmon calcitonin nasal spray.CTRI/2010/091/002958Glenmark Pharmaceuticals Ltd40
已完成
3 期
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm AssessmentBreast CancerNCT00122356Barwon Health303
已完成
不适用
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) StudyBone Diseases, MetabolicHip FracturesOsteoporosisNCT01360099National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)120